<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2026-11-05</publicationDate>
    
        <volume>19</volume>
        <issue>4</issue>

 
    <startPage></startPage>
    <endPage></endPage>

	    <publisherRecordId>74048</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Crosstalk Between Metabolic Reprogramming and Epigenetic Modifications in Relation to Cancer</title>

    <authors>
	 


      <author>
       <name>Mayank Chaudhary</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Sakshi</name>


		
	<affiliationId>1</affiliationId>

      </author>
    

	 


      <author>
       <name>Ranjay Kumar Choudhary</name>

		
	<affiliationId>2</affiliationId>
      </author>
    

	 


      <author>
       <name>Ashok Kumar Sah</name>

		
	<affiliationId>2</affiliationId>
      </author>
    


	 


      <author>
       <name>Vivek Kumar Garg</name>

		
	<affiliationId>3</affiliationId>
      </author>
    


	 


      <author>
       <name>Pooja Sharma</name>

		
	<affiliationId>1</affiliationId>
      </author>
    
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Bio-Sciences and Technology, Maharishi Markandeshwar (Deemed to be University), Mullana (Ambala)-133207, Haryana, India.</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Medical Laboratory Sciences, College of Applied and Health Sciences, A’Sharqiyah University, Sultanate of Oman</affiliationName>
    
		
		<affiliationName affiliationId="3">Department of Medical Lab Sciences (USAHS), Rayat-Bahra University, Mohali, Punjab, India.</affiliationName>
    
		
		
		
	  </affiliationsList>






    <abstract language="eng">Epigenetic modifications and metabolic reprogramming are inter-related and can affect each other’s regulation. The activities of metabolic pathways get altered during tumorigenesis and cancer progression. Change in metabolite levels can influence chromatin modifying enzymes (DNA and histone methyltransferase, DNA and histone demethylase, histone acetyltransferase, histone deacetylase) which in turn target cellular metabolism. Metabolites like acetyl-CoA, NAD<sup>+ </sup>(Nicotinamide adenine dinucleotide), SAM (S-adenosylmethionine), α-KG (Alpha-Ketoglutarate) and succinate that are intermediate products of glucose, fatty acids and amino acids metabolism can serve as essential cofactors for these epigenetic regulators. Translocation or relocalization of such cofactors and substrates can have severe impact on the activity of these chromatin modifying enzymes. Current studies have emphasized the involvement of metabolic changes and epigenetic modifications in driving immune escape and enhancing tumor progression. Thus, exploring mechanisms through which epigenetic modifications reprogram tumor cell metabolism can enhance our understanding of tumor pathogenesis and can lead to effective cancer therapies. Current review highlights the role of cellular metabolites on epigenetic modifications like methylation, acetylation, phosphorylation, succinylation and lactylation in relation to cancer. As a result, metabolic reprogramming and epigenetic modifications within tumor cells can be targeted as a potential therapeutic strategy against cancer.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol19no4/crosstalk-between-metabolic-reprogramming-and-epigenetic-modifications-in-relation-to-cancer/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Cancer</keyword>
      

      
        <keyword> Epigenetics</keyword>
      

      
        <keyword> Histone modifications</keyword>
      

      
        <keyword> Metabolic reprogramming</keyword>
      

      
        <keyword> Methylation</keyword>
      

      
        <keyword> Tumorigenesis</keyword>
      
</keywords>
  </record>
</records>